Bioventus Inc.

NASDAQ: BVS · Real-Time Price · USD
7.36
0.02 (0.27%)
At close: Aug 15, 2025, 3:59 PM
7.37
0.14%
After-hours: Aug 15, 2025, 05:36 PM EDT

Bioventus Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 28, 2025 Mar 29, 2025 Dec 31, 2024 Sep 28, 2024 Jun 29, 2024 Mar 30, 2024 Dec 31, 2023 Sep 30, 2023 Jul 1, 2023 Apr 1, 2023 Dec 31, 2022 Oct 1, 2022 Jul 2, 2022 Apr 2, 2022 Dec 31, 2021 Oct 2, 2021 Jul 3, 2021 Apr 3, 2021
Revenue
147.66M 123.88M 153.64M 138.96M 151.22M 129.46M 135.42M 120.79M 137.07M 119.06M 125.83M 128.66M 140.33M 117.29M 130.41M 108.89M 109.82M 81.78M
Cost of Revenue
45.57M 40.82M 50.99M 45.41M 47.58M 41.08M 49.12M 41.94M 47.95M 45.14M 51.65M 44.13M 43.68M 41.59M 42.65M 29.82M 33.5M 22.22M
Gross Profit
102.09M 83.06M 102.66M 93.55M 103.64M 88.38M 86.3M 78.85M 89.12M 73.92M 74.19M 84.53M 96.65M 75.7M 87.77M 79.07M 76.31M 59.56M
Operating Income
18.37M 4.87M 7.99M 4.07M -29.37M 5.33M 1.17M 2.42M 6.75M -92.06M -25.43M -126.84M -3.31M -21.45M -3.15M -1.05M -5.74M 22M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.55M n/a n/a n/a 2.88M
Pretax Income
10.31M -3.42M 232K -4.83M -39.45M -5.08M -8.41M -8.19M -4.35M -100.16M -49.71M -130.56M -6.77M -19.94M -4.62M -3.15M -9.07M 24.45M
Net Income
7.46M -2.64M -156K -4.82M -23.99M -4.57M -6.1M -7.3M -3.68M -139.15M -31.93M -108.25M -7.25M -11.28M -364K -1.07M -4.13M 24.94M
Selling & General & Admin
79.11M 73.5M 86.61M 81.09M 94.78M 78.41M 78.36M 69.82M 74.84M 80.86M 77.44M 78.95M 89.62M 86.12M 80.88M 69.64M 69.05M 34.69M
Research & Development
3.17M 3.01M 3.25M 3.81M 3.99M 2.6M 3.26M 3.02M 3.4M 3.77M 6.81M 4.61M 6.37M 6.93M 7.1M 6.15M 4.84M 947K
Other Expenses
1.44M 1.67M 4.81M n/a 34.23M 2.05M n/a 3.6M 4.13M 81.35M 15.15M n/a 3.98M 4.1M 2.93M 4.33M 8.17M 1.93M
Operating Expenses
83.72M 78.19M 94.67M 84.9M 133.01M 83.05M 85.14M 76.43M 82.37M 86.76M 89.83M 211.37M 99.96M 97.15M 90.92M 80.12M 82.05M 37.56M
Interest Expense
7.49M 7.51M 9M 9.53M 9.92M 10.34M 10.28M 10.12M 10.59M 9.69M 14.87M 3.6M 2.58M n/a 960K 1.35M 1.68M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a 3.85M n/a n/a n/a 5.2M n/a n/a n/a 3.87M n/a n/a n/a
Cost & Expenses
129.29M 119.01M 145.65M 130.31M 180.59M 124.13M 134.26M 118.38M 130.32M 211.12M 141.47M 255.5M 143.64M 138.74M 133.56M 109.94M 115.56M 59.78M
Income Tax Expense
1.04M -95K 550K 589K -7.34M 907K -750K 600K 381K -146K -4.84M -29.52M 1.24M -5.13M -2.73M -882K 1.71M -73K
Shares Outstanding (Basic)
66.5M 66.01M 65.45M 65.26M 64.06M 63.38M 63.1M 62.82M 62.55M 62.12M 61.93M 61.67M 61.48M 60.48M 45.47M 41.84M 41.81M 41.8M
Shares Outstanding (Diluted)
68.54M 66.01M 65.45M 65.26M 64.06M 63.38M 63.1M 62.82M 62.55M 62.12M 61.93M 61.67M 61.48M 60.48M 54.73M 41.84M 41.81M 41.8M
EPS (Basic)
0.11 -0.04 -0.00 -0.07 -0.37 -0.07 -0.1 -0.12 -0.06 -2.24 -0.52 -1.18 -0.11 -0.19 -0.01 -0.03 -0.1 0.60
EPS (Diluted)
0.11 -0.04 -0.00 -0.07 -0.37 -0.07 -0.1 -0.12 -0.06 -2.24 -0.52 -1.18 -0.11 -0.19 -0.01 -0.03 -0.1 0.60
EBITDA
29.86M 15.96M 21.63M 16.98M -16.44M 17.05M 14.34M 15.75M 20.84M -74M -5.7M -96M 8.19M -8.13M 8.77M 6.72M 8.05M 29.18M
EBIT
17.81M 4.09M 9.23M 4.7M -29.53M 5.26M 1.87M 1.92M 6.24M -90.47M -34.86M -126.95M -3.91M -20.6M -3.66M -1.8M 575K 22M
Depreciation & Amortization
12.05M 11.87M 12.4M 12.28M 13.09M 11.79M 12.46M 13.83M 14.6M 16.47M 23.16M 13.59M 12.38M 12.48M 11.69M 8.52M 7.48M 7.18M